--- title: "Avanos Medical (AVNS.US) — 财务报表" type: "Symbol" locale: "zh-CN" url: "https://longbridge.com/zh-CN/quote/AVNS.US/norm.md" symbol: "AVNS.US" name: "Avanos Medical" parent: "https://longbridge.com/zh-CN/quote/AVNS.US.md" datetime: "2026-05-20T13:04:56.327Z" locales: - [en](https://longbridge.com/en/quote/AVNS.US/norm.md) - [zh-CN](https://longbridge.com/zh-CN/quote/AVNS.US/norm.md) - [zh-HK](https://longbridge.com/zh-HK/quote/AVNS.US/norm.md) --- # Avanos Medical (AVNS.US) — 财务报表 ## 利润表 (USD) | 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | | --- | --- | --- | --- | --- | --- | | 每股收益 | 0.1097 | -0.0280 | -0.0302 | -1.66 | 0.1400 | | ROE | 2.61% | -0.67% | -0.72% | -38.03% | 3.17% | | 营业收入 | 182.20M | 180.90M | 177.80M | 175.00M | 167.50M | | 净利润 | 5.10M | -1.30M | -1.40M | -76.80M | 6.60M | | 营业利润 | 9.80M | 3.60M | 500000.00 | 2.50M | 8.90M | | 毛利率 | 51.70% | 47.54% | 48.37% | 52.63% | 53.61% | | 净利率 | 2.80% | -0.72% | -0.79% | -43.89% | 3.94% | | 利润含金量 | -79.67% | 12.77% | 3.57% | 36.76% | 34.63% | ## 资产负债表 (USD) | 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | | --- | --- | --- | --- | --- | --- | | 资产与负债 | 1.05B | 1.07B | 1.07B | 1.04B | 1.11B | | 权益乘数 | 1.34 | 1.38 | 1.37 | 1.34 | 1.32 | | 每股净资产 | 16.76 | 16.75 | 16.76 | 16.76 | 18.15 | | 资产周转率 | 0.6635 | 0.6295 | 0.5139 | 0.5136 | 0.4978 | | 现金及短投 | 65.60M | 89.80M | 70.50M | 90.30M | 97.00M | | 存货与应收 | 141.30M | 148.00M | 150.60M | 142.70M | 138.10M | | 长期投资 | 150.50M | 141.00M | 145.30M | 145.40M | 141.90M | | 净债务 | 72.80M | 39.30M | 63.20M | 47.00M | 43.90M | ## 现金流量表 (USD) | 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | | --- | --- | --- | --- | --- | --- | | 经营现金流 | -12.30M | 28.20M | 14.00M | 6.80M | 25.70M | | 投资现金流 | -7.70M | -6.80M | -31.50M | -13.20M | -9.10M | | 融资现金流 | -3.20M | -2.70M | -2.00M | -3.20M | -29.10M | | 自由现金流 | -14.97M | 39.55M | 5.21M | -8.24M | 14.36M | | 现金流充裕率 | -186.36% | 303.23% | 150.54% | 50.75% | 75.59% | | 举债与偿债 | - | - | - | - | - | | 资本支出 | -4.30M | -6.90M | -7.00M | -11.00M | -6.70M |